These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 30643167)
1. KRAS mutations drive adenomatoid odontogenic tumor and are independent of clinicopathological features. Coura BP; Bernardes VF; de Sousa SF; França JA; Pereira NB; Pontes HAR; Batista AC; da Cruz Perez DE; Albuquerque Junior RLC; de Souza LB; Martins MD; Diniz MG; Gomez RS; Gomes CC Mod Pathol; 2019 Jun; 32(6):799-806. PubMed ID: 30643167 [TBL] [Abstract][Full Text] [Related]
2. Detection of MAPK/ERK pathway proteins and KRAS mutations in adenomatoid odontogenic tumors. Bologna-Molina R; Ogawa I; Mosqueda-Taylor A; Takata T; Sánchez-Romero C; Villarroel-Dorrego M; Takeda Y; Mikami T Oral Dis; 2019 Mar; 25(2):481-487. PubMed ID: 30294831 [TBL] [Abstract][Full Text] [Related]
3. Adenoid ameloblastoma with dentinoid is molecularly different from ameloblastomas and adenomatoid odontogenic tumors. Coura BP; Dos Santos JN; Fonseca FP; Bernardes VF; de Aquino SN; Jorge Júnior J; Vargas PA; Romañach MJ; de Andrade BAB; Gomez RS; Gomes CC J Oral Pathol Med; 2021 Nov; 50(10):1067-1071. PubMed ID: 34549835 [TBL] [Abstract][Full Text] [Related]
4. BRAF V600E and previously unidentified KRAS G12C mutations in odontogenic tumors may affect MAPK activation differently depending on tumor type. Oh KY; Kim JH; Cho SD; Yoon HJ; Lee JI; Hong SD Genes Chromosomes Cancer; 2022 Aug; 61(8):481-490. PubMed ID: 35353428 [TBL] [Abstract][Full Text] [Related]
5. Assessing pathogenic mutations in dental follicles as an attempt to identify early events in odontogenic tumours tumourigenesis. Coura BP; de Resende TAC; de Menezes VCB; Bernardes VF; de Sousa SF; Diniz MG; Gomez RS; Gomes CC Arch Oral Biol; 2020 May; 113():104523. PubMed ID: 31543246 [TBL] [Abstract][Full Text] [Related]
7. Relationships among Wan XB; Wang AQ; Cao J; Dong ZC; Li N; Yang S; Sun MM; Li Z; Luo SX World J Gastroenterol; 2019 Feb; 25(7):808-823. PubMed ID: 30809081 [TBL] [Abstract][Full Text] [Related]
8. Genetic Profile of Adenomatoid Odontogenic Tumor and Ameloblastoma. A Systematic Review. Marín C; Niklander SE; Martínez-Flores R Front Oral Health; 2021; 2():767474. PubMed ID: 35048068 [No Abstract] [Full Text] [Related]
9. Analyses of clinicopathological, molecular, and prognostic associations of KRAS codon 61 and codon 146 mutations in colorectal cancer: cohort study and literature review. Imamura Y; Lochhead P; Yamauchi M; Kuchiba A; Qian ZR; Liao X; Nishihara R; Jung S; Wu K; Nosho K; Wang YE; Peng S; Bass AJ; Haigis KM; Meyerhardt JA; Chan AT; Fuchs CS; Ogino S Mol Cancer; 2014 May; 13():135. PubMed ID: 24885062 [TBL] [Abstract][Full Text] [Related]
10. The molecular basis of odontogenic cysts and tumours. Gomes IP; Bastos VC; Guimarães LM; Gomes CC J Oral Pathol Med; 2023 Apr; 52(4):351-356. PubMed ID: 36629457 [TBL] [Abstract][Full Text] [Related]
11. Mutation status and prognostic value of KRAS and NRAS mutations in Moroccan colon cancer patients: A first report. El Agy F; El Bardai S; El Otmani I; Benbrahim Z; Karim MH; Mazaz K; Benjelloun EB; Ousadden A; El Abkari M; Ibrahimi SA; Chbani L PLoS One; 2021; 16(3):e0248522. PubMed ID: 33784337 [TBL] [Abstract][Full Text] [Related]
12. Adenoid Ameloblastoma with BRAF p.V600E Mutation Revealing Ameloblastomatous Origin: A First Case Report. Noda Y; Sawada S; Sakagami T; Kojima Y; Higasa K; Tsuta K Head Neck Pathol; 2023 Sep; 17(3):788-792. PubMed ID: 37093491 [TBL] [Abstract][Full Text] [Related]
13. The Molecular Pathology of Odontogenic Tumors: Expanding the Spectrum of MAPK Pathway Driven Tumors. Guimarães LM; Coura BP; Gomez RS; Gomes CC Front Oral Health; 2021; 2():740788. PubMed ID: 35048058 [TBL] [Abstract][Full Text] [Related]
14. [Mutations of KRAS and BRAF in Chinese patients with colorectal carcinoma: analyses of 966 cases]. Gao J; Sun ZW; Li YY; Shen L Zhonghua Bing Li Xue Za Zhi; 2012 Sep; 41(9):579-83. PubMed ID: 23157823 [TBL] [Abstract][Full Text] [Related]
15. RAS/RAF mutations and their associations with epigenetic alterations for distinct pathways in Vietnamese colorectal cancer. Ta TV; Nguyen QN; Chu HH; Truong VL; Vuong LD Pathol Res Pract; 2020 Apr; 216(4):152898. PubMed ID: 32089414 [TBL] [Abstract][Full Text] [Related]
16. [Correlation between KRAS mutations and clinicopathologic features in colorectal carcinomas]. Gao J; Zhang J; Lu T; Li XY; Jia N; Liang ZY Zhonghua Bing Li Xue Za Zhi; 2012 Sep; 41(9):595-8. PubMed ID: 23157826 [TBL] [Abstract][Full Text] [Related]
17. K-Ras gene status and expression of Ras/mitogen-activated protein kinase (MAPK) signaling molecules in ameloblastomas. Kumamoto H; Takahashi N; Ooya K J Oral Pathol Med; 2004 Jul; 33(6):360-7. PubMed ID: 15200485 [TBL] [Abstract][Full Text] [Related]